Non-Invasive Diagnosis and Monitoring of Cardiac Masses by Liquid Biopsy
Recruiting now
Conditions studied: Cardiac Masses
In brief
This is a nonprofit, observational, prospective and retrospective,multicenter study in a population of young and adult patients ≥12 years with a diagnosis of a cardiac mass. The study will include both patients with masses of unknown pathological diagnosis and patients with a known histology of benign or malignant tumors. We predict a case-control allocation ratio of 1:1 between cardiac malignant tumors and benign lesions. Peripheral blood will be collected at participating centers during routine venipuncture,processed and then shipped for liquid biopsy ctDNA NGS analyses. If available, in malignant cases, matched tumor tissue samples collected as per clinical practice solid biopsies or surgery will be used for analyses. Longitudinal tracking through serial blood draws could be performed in selected cases of patients with cardiac malignancies who receive cancer treatment
Key facts
- Study ID
- NCT07235865
- Run by
- Niguarda Hospital
- People needed
- 26
- Starts
- 2024-07-25
- Expected to finish
- 2026-12-25
- Last updated by the study team
- 2026-04-15
Who can join
Age: 12 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥12 years old
- Suspected or confirmed diagnosis of a cardiac mass of any nature as assessed by standard clinical, radiological and/or pathological procedures.
You may not qualify if…
- Inability of the pa ent to fully understand and sign the informed consent.
Where it is running
- Niguarda Hospital — Milan, Italia, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.